Amphastar Pharmaceuticals, Inc.
AMPH
$22.81
-$0.12-0.52%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 183.90M | 171.17M | 183.11M | 191.84M | 174.41M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 183.90M | 171.17M | 183.11M | 191.84M | 174.41M |
| Cost of Revenue | 90.43M | 100.85M | 97.44M | 93.19M | 87.92M |
| Gross Profit | 93.47M | 70.32M | 85.67M | 98.65M | 86.49M |
| SG&A Expenses | 31.58M | 29.96M | 26.75M | 27.87M | 24.23M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 144.17M | 157.54M | 147.50M | 143.42M | 132.23M |
| Operating Income | 39.73M | 13.63M | 35.61M | 48.42M | 42.18M |
| Income Before Tax | 38.54M | 10.05M | 31.91M | 21.51M | 39.34M |
| Income Tax Expenses | 8.20M | 3.63M | 7.49M | 4.16M | 8.31M |
| Earnings from Continuing Operations | 30.35M | 6.42M | 24.43M | 17.35M | 31.03M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 30.35M | 6.42M | 24.43M | 17.35M | 31.03M |
| EBIT | 39.73M | 13.63M | 35.61M | 48.42M | 42.18M |
| EBITDA | 54.04M | 27.98M | 49.95M | 62.55M | 56.80M |
| EPS Basic | 0.70 | 0.14 | 0.53 | 0.37 | 0.66 |
| Normalized Basic EPS | 0.55 | 0.14 | 0.43 | 0.60 | 0.52 |
| EPS Diluted | 0.67 | 0.14 | 0.51 | 0.37 | 0.64 |
| Normalized Diluted EPS | 0.54 | 0.14 | 0.42 | 0.58 | 0.51 |
| Average Basic Shares Outstanding | 43.64M | 45.32M | 45.91M | 46.47M | 46.95M |
| Average Diluted Shares Outstanding | 44.23M | 46.46M | 47.16M | 47.68M | 48.13M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |